GlaxoSmithKline (GSK), with operations in some 120 countries, is engaged in the creation, discovery, development, manufacture, and marketing of pharmaceutical and consumer healthcare products.
Working across an international network of manufacturing sites, GSK supplies product to patients and customers in over 150 countries.
What you may not know is that GSK Contract Manufacturing offers a fully integrated supply chain solution to support your projects at every level: from early stage research and development, to clinical supply, to launch and growth of small, medium, and large volume products.
We have state-of-the-art facilities for the manufacture of:
Biopharmaceuticals: bulk biopharmaceutical products as well as fill-finish capabilities
API: Traditional Small Molecule, Micronization, co-located R&D Pilot Plants
Steriles: Lyophilization, Syringes, Vials, Ampoules
Solid Dose: Immediate, controlled, and extended release tablets and capsules,
Bi-Layer and Tri-Layer Tablets, DiffCORE® Technology, High Containment
Cephalosporins and Penicillins: Solid Dose, Oral Liquids, Vials
Liquids, Creams, and Ointments: Liquid Dispensing Technology (LDT)
Respiratory Dose Forms: Metered Dose and Dry Powder Inhalers
With our highly professional staff, experienced in cGMP manufacturing, we can provide all the advantages you need for a successful contract manufacturing partnership:
Quality is a mindset that underpins the whole ethos of how we work. It means doing what is right, first time, every time. GSK is at the forefront of process optimization with the application of methodologies that include Process Analytical Technology (PAT) and Quality by Design (QbD). A testament to this is our excellent quality, regulatory, compliance, and environmental facilities record.
GSK has dedicated, state-of-the-art facilities for the manufacture of products from actives through bulk and finished product supply. We have comprehensive laboratory facilities to support quality, product development, engineering, and physical properties analysis with state-of-the-art instrumentation. Our manufacturing has support from comprehensive corporate resources, including Chemistry and Pharmaceutical Development. We can offer co-located R&D API Pilot Plants, where we can provide early phase clinical requirements as well as commercial scale-up.
Of particular note, we offer full-service high-containment capabilities for potent and cytotoxic compounds from API manufacturing through to finished product in sterile vials, capsules, or tablets.
We are committed to security of supply. The combination of our in-house manufacturing capabilities and world-class logistics operations means we have a sound track record in ensuring patients and customers have the products they need, on time and in full.
We have a culture of continuous improvement coupled with operational excellence and lean sigma. We are committed to removing waste and complexity from our operations so that we can deliver competitively priced products of the highest quality.
For more information about our capabilities: call +1 877-779-0296 or contact us by email*.
* Please note that this email address should not be used for reporting side effects of medicines. If you want to report a side effect, please call the GSK Response Center in the US on 1-888-825-5249 or the Customer Contact Centre in the UK on 0800 221441. For other locations, please contact your local GSK office.
“Molecule to Market — Extending Your Capabilities”
DiffCORE®, GlaxoSmithKline, and the GlaxoSmithKline logo are trademarks of the GlaxoSmithKline group of companies.
Download our PDF brochures: